SUBLIMEVA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SUBLIMEVA
Largest movements
- Current investments +€272,705
up €272,705 (+52896.0%), from €516 to €273,221
- Deferred charges and accrued income +€19,750
up €19,750 (+13.1%), from €150,432 to €170,182
- Profit (loss) carried forward +€299,518
up €299,518 (+26.4%), from -€1.1m to -€836,526
- Financial income +€286,379
up €286,379 (+1449.8%), from €19,753 to €306,132
- Gross operating margin +€1,099
up €1,099 (+17.3%), from -€6,351 to -€5,252
- Financial charges +€75
up €75 (+26.2%), from €288 to €363
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,249,960 | €1,557,137 | +€307,177 | +24.6% |
| Fixed assets | 21/28 | €1,098,241 | €1,098,241 | = | 0.0% |
| Financial fixed assets | 28 | €1,098,241 | €1,098,241 | = | 0.0% |
| Current assets | 29/58 | €151,719 | €458,896 | +€307,177 | +202.5% |
| Amounts receivable within one year | 40/41 | €10 | - | -€10 | |
| Other amounts receivable | 41 | €10 | - | -€10 | |
| Current investments | 50/53 | €516 | €273,221 | +€272,705 | +52896.0% |
| Cash at bank and in hand | 54/58 | €762 | €15,494 | +€14,732 | +1934.5% |
| Deferred charges and accrued income | 490/1 | €150,432 | €170,182 | +€19,750 | +13.1% |
| Total equity and liabilities | 10/49 | €1,249,960 | €1,557,137 | +€307,177 | +24.6% |
| Equity | 10/15 | €1,249,875 | €1,549,393 | +€299,518 | +24.0% |
| Contributions | 10/11 | €2,385,919 | €2,385,919 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€1,136,044 | -€836,526 | +€299,518 | +26.4% |
| Amounts payable | 17/49 | €85 | €7,744 | +€7,659 | +9000.2% |
| Amounts payable within one year | 42/48 | - | €7,744 | +€7,744 | |
| Other amounts payable | 47/48 | - | €7,744 | +€7,744 | |
| Accrued charges and deferred income | 492/3 | €85 | - | -€85 | |
| Other operating charges | 640/8 | €968 | €998 | +€31 | +3.2% |
| Gross operating margin | 9900 | -€6,351 | -€5,252 | +€1,099 | +17.3% |
| Operating profit (loss) | 9901 | -€7,318 | -€6,250 | +€1,068 | +14.6% |
| Financial income | 75/76B | €19,753 | €306,132 | +€286,379 | +1449.8% |
| Recurring financial income | 75 | €19,753 | €306,132 | +€286,379 | +1449.8% |
| Financial charges | 65/66B | €288 | €363 | +€75 | +26.2% |
| Recurring financial charges | 65 | €288 | €363 | +€75 | +26.2% |
| Profit (loss) for the period before taxes | 9903 | €12,147 | €299,519 | +€287,372 | +2365.8% |
| Income taxes | 67/77 | €1 | €1 | -€0 | -23.6% |
| Profit (loss) for the period | 9904 | €12,146 | €299,518 | +€287,372 | +2366.0% |
| Profit (loss) for the period to be appropriated | 9905 | €12,146 | €299,518 | +€287,372 | +2366.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.